Advice

Following a full submission

esomeprazole (Nexium®) is accepted for use within NHS Scotland for the treatment of Zollinger-Ellison Syndrome.

Other proton pump inhibitors are available for this indication at a lower cost per treatment period.

Download detailed advice50KB (PDF)

Download

Medicine details

Medicine name:
esomeprazole (Nexium)
SMC ID:
422/07
Indication:
Zollinger-Ellison syndrome
Pharmaceutical company
AstraZeneca UK Ltd
BNF chapter
Gastro-intestinal system
Submission type
Full
Status
Accepted
Date advice published
10 December 2007